Alain Badorc

New Orally Active Non-Peptide Fibrinogen Receptor (GpIIb-IIIa) Antagonists:  Identification of Ethyl 3-[<i>N</i>-[4-[4-[Amino[(ethoxycarbonyl)imino]methyl]phenyl]- 1,3-thiazol-2-yl]-<i>N</i>-[1-[(ethoxycarbonyl)methyl]piperid-4-yl]amino]propionate (SR 121787) as a Potent and Long-Acting Antithrombotic Agent

Alain Badorc, Marie-Françoise Bordes, P. DE COINTET et al. · Journal of Medicinal Chemistry · 1997 · 127 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

<i>N</i>-[6-(4-Butanoyl-5-methyl-1<i>H</i>-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1<i>H</i>-indole-3-carboxamide (SAR216471), a Novel Intravenous and Oral, Reversible, and Directly Acting P2Y12 Antagonist

Christophe Boldron, Angélina Besse, Marie-Françoise Bordes et al. · Journal of Medicinal Chemistry · 2014 · 49 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

SR 121787, a New Orally Active Fibrinogen Receptor Antagonist

Pierre Savi, Alain Badorc, Alain Lalé et al. · Thrombosis and Haemostasis · 1998 · 16 citations

Medicine, Hematology, Pharmacology +17

New synthesis of 5,6,7,8‐tetrahydro‐4<i>H</i>‐thieno[2,3‐<i>d</i>]azepine

D. FREHEL, Alain Badorc, Jean‐Marie Pereillo et al. · Journal of Heterocyclic Chemistry · 1985 · 11 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9